Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment (scientific article)

The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride

Q45047801

A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.

Q45284807

Dopamine D(2) receptor availability is associated with subjective responses to alcohol

Q46565122

The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study

Q48173319

Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving

Q48421523

Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

Q48496653

Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies

Q48623993

PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects

Q48631046

Simplified reference tissue model for PET receptor studies.

Q48832665

Nicotine chemistry, metabolism, kinetics and biomarkers

Q24632647

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

Q29301836

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Q29615435

Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [¹⁸F]fallypride study in cocaine dependent participants

Q30541641

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

Q31871442

Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens

Q33865234

Role of dopamine in the behavioural actions of nicotine related to addiction

Q33894548

Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers

Q33960519

Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study

Q34054242

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

Q34269010

Sex differences in the brain's dopamine signature of cigarette smoking

Q34664357

Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse

Q34757772

Prefrontal and limbic resting state brain network functional connectivity differs between nicotine-dependent smokers and non-smoking controls.

Q36074911

The development and initial validation of a questionnaire on smoking urges

Q39506506

Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens

Q41257930

Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion.

Q43300290

Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey

Q43482362

Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine

Q43783796

P433

issue

P921

main subject

striatum

Q1319792

P304

page(s)

486-492

P577

publication date

2016-07-28

P1433

published in

American Journal on Addictions

Q15762371

P1476

title

Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment

P478

volume

Reverse relations

cites work (P2860)

Q90130185	Caudate reactivity to smoking cues is associated with increased responding to monetary reward in nicotine-dependent individuals
Q51245385	Effect of combined naltrexone and bupropion therapy on the brain's functional connectivity.
Q92465239	Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies